Egyptian International Pharmaceutical Industries Company (EGX:PHAR)
Egypt flag Egypt · Delayed Price · Currency is EGP
81.05
-1.94 (-2.34%)
At close: Feb 22, 2026

EGX:PHAR Ratios and Metrics

Millions EGP. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
13,8406,8295,4303,6214,1554,309
Market Cap Growth
102.16%25.78%49.96%-12.86%-3.57%-34.63%
Enterprise Value
22,18714,5789,6305,3885,5095,532
Last Close Price
82.0143.1732.6823.7125.0524.17
PE Ratio
11.016.236.605.638.528.86
Forward PE
10.807.035.925.776.237.52
PS Ratio
1.490.901.040.921.221.49
PB Ratio
2.131.471.271.121.401.51
P/TBV Ratio
2.251.481.281.121.401.52
P/OCF Ratio
24.35-58.71-10.8326.14
PEG Ratio
-0.760.760.760.760.76
EV/Sales Ratio
2.391.921.841.361.621.92
EV/EBITDA Ratio
8.799.127.337.106.357.61
EV/EBIT Ratio
9.189.707.958.147.099.42
EV/FCF Ratio
-15.22-----
Debt / Equity Ratio
1.421.981.150.880.590.63
Debt / EBITDA Ratio
3.895.763.743.762.032.47
Net Debt / Equity Ratio
1.241.701.000.730.490.37
Net Debt / EBITDA Ratio
3.404.963.233.131.671.46
Net Debt / FCF Ratio
-5.53-1.92-1.93-2.77-27.25-27.43
Asset Turnover
0.580.600.630.660.660.61
Inventory Turnover
1.461.461.361.211.081.03
Quick Ratio
0.470.450.650.540.671.02
Current Ratio
1.431.381.941.722.132.13
Return on Equity (ROE)
22.48%24.60%21.95%20.71%16.78%16.81%
Return on Assets (ROA)
8.83%7.41%9.04%6.89%9.46%7.77%
Return on Invested Capital (ROIC)
11.71%10.36%13.21%10.69%14.11%13.37%
Return on Capital Employed (ROCE)
20.10%15.80%16.90%16.10%21.70%17.70%
Earnings Yield
9.08%16.04%15.14%17.76%11.74%11.29%
FCF Yield
-10.53%-60.34%-40.48%-23.75%-1.28%-0.90%
Dividend Yield
1.85%3.48%3.06%4.22%5.99%-
Payout Ratio
48.57%39.61%37.67%61.14%78.64%103.41%
Buyback Yield / Dilution
-13.45%--50.00%--1.64%1.61%
Total Shareholder Return
-11.59%3.48%-46.94%4.22%4.35%1.61%
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.